User profiles for Pamela Kearns

Pamela Kearns

Professor of clinical paediatric oncology, University of Birmingham
Verified email at bham.ac.uk
Cited by 4956

[HTML][HTML] Challenges to curing primary brain tumours

…, EC Holland, DTW Jones, JA Joyce, P Kearns… - Nature reviews Clinical …, 2019 - nature.com
Despite decades of research, brain tumours remain among the deadliest of all forms of cancer.
The ability of these tumours to resist almost all conventional and novel treatments relates, …

The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo

…, G Smith, JE Powell, Z Rudzki, P Kearns… - Blood, The Journal …, 2010 - ashpublications.org
The Ataxia Telangiectasia Mutated (ATM) gene is frequently inactivated in lymphoid malignancies
such as chronic lymphocytic leukemia (CLL), T-prolymphocytic leukemia (T-PLL), and …

The COVID‐19 pandemic: a rapid global response for children with cancer from SIOP, COG, SIOP‐E, SIOP‐PODC, IPSO, PROS, CCI, and St Jude Global

…, S Luna‐Fineman, MS Khan, P Kearns… - Pediatric blood & …, 2020 - Wiley Online Library
The COVID‐19 pandemic is one of the most serious global challenges to delivering affordable
and equitable treatment to children with cancer we have witnessed in the last few decades…

Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target

…, G Pratt, KP U, A Lo, M Ng, P Kearns… - Blood, The Journal …, 2015 - ashpublications.org
Acute myeloid leukemia (AML) is one of the most common acute leukemias in adults and
children, yet significant numbers of patients relapse and die of disease. In this study, we identify …

[HTML][HTML] Severity of COVID-19 in children with cancer: report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project

…, RS Phillips, CA Stiller, C Várnai, PR Kearns - British journal of …, 2021 - nature.com
Background Children with cancer are frequently immunocompromised. While children are
generally thought to be at less risk of severe SARS-CoV-2 infection than adults, …

Expression of CD133 on leukemia-initiating cells in childhood ALL

…, P Diamanti, RS Evely, PR Kearns… - Blood, The Journal of …, 2009 - ashpublications.org
Optimization of therapy for childhood acute lymphoblastic leukemia (ALL) requires a greater
understanding of the cells that proliferate to maintain this malignancy because a significant …

Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia

CV Cox, HM Martin, PR Kearns, P Virgo, RS Evely… - Blood, 2007 - ashpublications.org
A significant proportion of children with T-cell acute lymphoblastic leukemia (T-ALL) continue
to fail therapy. Consequently, characterization of the cells that proliferate to maintain the …

[HTML][HTML] Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study …

…, M Ost, C Magni, P Kearns… - European journal of …, 2019 - Elsevier
Although all tumours are rare in childhood, there are some particularly rare paediatric cancers
which have not benefited from advances made by the international paediatric oncology …

Examining the immunological effects of COVID-19 vaccination in patients with conditions potentially leading to diminished immune response capacity–the OCTAVE …

P Kearns, S Siebert, C Gaskell, A Kirkham, S Pirrie… - 2021 - papers.ssrn.com
SARS-COV-2 vaccines have been shown to be efficacious primarily in healthy volunteer
populations and population level studies. Immune responses following SARS-CoV-2 …

[HTML][HTML] Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm …

…, J Bion, S Gates, D Richards, P Kearns… - The Lancet …, 2022 - thelancet.com
Background Dysregulated inflammation is associated with poor outcomes in COVID-19. We
aimed to assess the efficacy of namilumab (a granulocyte-macrophage colony stimulating …